812results about How to "High detection specificity" patented technology

The present invention relates to an automatable method for obtaining an improved diagnosis of cancer, and its precancerous stages in uterine cervical smears by simultaneously staining and detecting at least two different molecular markers, which exhibit a disease-associated change in gene expression, in a cell by means of using antibodies or nucleic acid probes.

A method for improving the sensitivity of an immunoassay by a factor of at least 10 to about 25, and perhaps greater. Furthermore, in addition to increasing the sensitivity of the assay, the method of this invention also improves assay specificity. In order to match or improve upon sensitivity of 0.2 pg/mL for an analyte, this invention provides an immunoassay involving amplification of a signal, e.g., a chemiluminescent signal, a specific binding member, e.g., a monoclonal antibody, and microparticle separation, e.g., magnetic microparticle separation, from large volumes of sample (e.g., from about 0.2 to about 3 mL). Such an immunoassay can be carried out with an automated immunoassay analyzers, e.g., an automated immunoassay analyzer in the ARCHITECT® family of analyzers.

In one aspect of the present invention, a method for calculating a response value at a first voxel indicative of a global shape in an image is provided. The method includes the steps of (a) determining at least one local shape descriptor associated with each of the at least one local shape descriptor; (b) determining a spread function associated with the each of the at least one local shape descriptor; (c) determining second voxels around the first voxel; (d) calculating values for each the at least one local shape descriptor at each of the second voxels; (e) determining a contribution of each of the second voxels at the first voxel based on the spread functions; and (f) using a combination function to combine the contributions to determine the response value indicative of the global shape.

Techniques are described for adaptively adjusting detection thresholds for use in detecting cardiac ischemia and other abnormal physiological conditions based on morphological parameters derived from intracardiac electrogram (IEGM) signals, impedance measurements, or other signals. In one example, where ST segment elevation is used to detect cardiac ischemia, default detection thresholds are determined in advance from an examination of variations in ST segment elevations occurring within a population of patients. Thereafter, an individual pacemaker or other implantable medical device uses the default thresholds during an initial learning period to detect ischemia within the patient in which the device is implanted. During the initial learning period, the pacemaker also collects data representative of the range of variation in ST segment elevations occurring within the patient. The pacemaker then adaptively adjusts the thresholds based on the range of variation so as to improve detection specificity within the patient.

Target-specific hybrid capture (TSHC) provides a nucleic acid detection method that is not only rapid and sensitive, but is also highly specific and capable of discriminating highly homologous nucleic acid target sequences. The method produces DNA-RNA hybrids which can be detected by a variety of methods.

The invention discloses a method for detecting nucleic acid by a colloidal gold chromatography technology and a reagent kit, and belongs to the technical field of medical biology. A universal test paper strip for nucleic acid detection is provided; colloidal gold particles are marked on a universal probe 1, and then, the universal probe is fixed on a glass cellulose membrane; the probe sequence is designed into a universal sequence; the test paper strip is fixed on a PVC (polyvinyl chloride) bottom plate; a sample pad, glass fiber, an NC membrane and water absorption paper are in sequential arrangement from the left side to the right side, wherein a T line (detection line) and a C line (quality control line) are arranged on the NC membrane; antibodies to labels b cover the detection line; antibodies to labels a cover the quality control line; the specificity probe A series and the specificity B series successfully combine a gold mark probe and nucleic acid amplification fragments in series; the specificity detection of nucleic acid amplification fragments is realized. The method has the advantages that the technical requirement on the experiment personnel is low; the required detection time is short; special instrument equipment is not needed; the popularization to basic levels and remote rural area medical institutions is easy.

The invention discloses an intestinal-tract-derived flora for diagnosing sarcopenia and use of the intestinal-tract-derived flora, and belongs to the biomedicine field. The flora contains Oscillibacter and Eubacterium_brachy_group. By detecting intestinal flora markers, the risk that a subject suffers from the sarcopenia can be evaluated, and auxiliary references are provided for diagnosis and treatment of diseases.

The invention provides a tumor exosome nanometer fluorescence sensor based on magnetic separation and DNA self-assembling. The sensor comprises a functionalized magnetic bead coupled with a GPC-1 antibody, a trigger chain, and three stem circular nucleic acid probes. According to the invention, quantitative detection of the GPC-1(+) exosome subgroup of the breast cancer is realized; and the detection specificity and sensitivity are high and the detection range is wide. The clinical application value of the method is evaluated by detecting the breast cancer GPC-1(+) exosome subgroup in the clinical plasma source specimen. The method having high universality not only can be applied to other biomarkers with specific aptamers screened out but also can be applied to detection of other exosome subgroups, proteins, cells and metal ions and the like.

The inventive subject matter relates to a method for the detection and diagnosis of Rickettsia prowazekii infection by measuring the increased or decreased expression of specific human genes following infection by microarray or polymerase chain reaction analysis. Gene modulation profiles can be further analyzed by computer. The method permits the early detection and diagnosis of Rickettsia prowazekii exposure and infection and diagnosis of epidemic typhus earlier than any currently available methods.

The invention relates to a technology for detecting nucleic acid and provides a nucleic acid detecting method having the advantages of high sensitivity, high accuracy, low cost, simple operation and quickness, and a nucleic acid film chromatographic hybrid strip thereof. The nucleic acid film chromatographic hybrid strip comprises a sampling pad, target nucleic acid sequence capturing probes, a chromatographic film, a water absorbent pad and a back lining, wherein the chromatographic film is bonded to the middle of the back lining; the sampling pad and the water absorbent pad are bonded to both ends of the chromatographic film respectively; and the target nucleic acid sequence capturing probes are fixed on the chromatographic film between the sampling pad and the water absorbent pad in a straight line. In the method, the colored fluorescence marking probes and the film chromatography technology are combined, the type of a template of a sample can be differentiated by two parameters, namely fluorescence and a physical position, so that the quick genotyping detection of nucleic acid is realized. The nucleic acid detecting method is high in sensitivity, and the detection sensitivity reaches 101 copies/reaction. The nucleic acid detecting method is high in specificity, the high specificity are jointly guaranteed by the primers, detection probes and capturing probes, so that the detection result is more stable and accurate.

The invention belongs to the field of biotechnology and clinical molecular diagnosis and in particular relates to a fluorescent genotyping detection kit and a detection method for eight human K-ras gene mutations. According to the method, an MGB (minor groove binder) probe technology is combined with a mismatch ARMS (amplification refractory mutation system) technology, an MGB probe complementary with a DNA (deoxyribonucleic acid) plus strand and an ARMS downstream primer complementary with a DNA minus strand are designed at allelic gene loci, a mismatch locus is introduced in the ARMS downstream primer, the MGB probe is overlapped with the ARMS primer by not more than 5 bp, and the eight human K-ras gene mutations are subjected to genotyping detection by four reaction pipes based on multiple fluorescent PCR (polymerase chain reaction). The method has the advantages of good specificity, high sensitivity, simplicity and quickness for operation, accuracy for genotyping, simplicity for result interpretation and the like, and can be used for detecting the clinical K-ras gene mutations and helping doctors screen the crowed with effective anti-EGFR (epidermal growth factor receptor) treatment.

The invention discloses a latex-enhanced immunoturbidimetric assay kit for neutropil gelatinase-associated lipocalin, and a preparation method thereof. Polyethylene glycol hexamine is selected as theblocking agent of an antibody binding latex particle. The kit used for latex-enhanced immunoturbidimetric assay of the NGAL has the advantages of high detection specificity, high sensitivity and goodstability, and can efficiently detect the NGAL content in urine, plasma and serum, and the detection result is well associated with fluorescence immunochromatography and enzyme linked immunosorbent assay.

The invention provides a primer, a probe, a reagent kit and a method for detecting mutation of BRAF gene V600E on the basis of real-time fluorescent quantitative PCR (polymerase chain reaction) technical platform. The primer, the probe, the reagent kit and the method are quick and low in cost and have clinic detection popularization value.

The invention discloses a time-resolved fluorescence immunoassay reagent kit which is used for detecting quinoxalinone-2-carboxylic acid and a detection method of the time-resolved fluorescence immunoassay reagent kit. The reagent kit comprises a porous coated plate, a buffer solution, quinoxalinone-2-carboxylic acid standard, freeze-dried antibodies of quinoxalinone-2-carboxylic acid, europium-marked goat anti mouse antibodies, a cleaning solution and an enhancement solution. By measuring fluorescence intensity of counts per second (cps), the content of quinoxalinone-2-carboxylic acid in samples is calculated by a standard curve. The kit provided by the invention has the advantages of simple structure, easiness in assembly, corrosion resistance, light weight, low cost, wide application and the like. A valve core has good centering performance and can move flexibly and reliably and can play a good water-plugging role.

The invention discloses a real-time fluorescence quantitative PCR(Polymerase Chain Reaction) detection kit and related primers for thalassemia genes. The kit comprises more than one pair of the following primers: SEQ ID NO.1 and SEQ ID NO.2 aiming at TATA kits nt-28 (A->G) (-28M), -29 (A->G) (-29M) and CAP-40-43 (AACC) (CAPM) genotypes; SEQ ID NO.3 and SEQ ID NO.4 aiming at CD14-15 (+G) (14-15M), CD17 (A->T) (17M) and the initiation codon mutant ATG->AGG(IntM) genotypes; SEQ ID NO.5 and SEQ ID NO.6 aiming at CD26 (G->A)(betaEM) CDs27-28+C(27-28M), IVS1-1(G->T)(IVS1-1M), IVS1-5(G->C)(IVS1-5M) genotypes; SEQ ID NO.7 and SEQ ID NO.8 aiming at CDs41-42-TCTT (41-42M), CD43G->T(43M), 41-42M/41-42M genotypes; SEQ ID NO.9 and SEQ ID NO.10 aiming at CD71-72(+A) (71-72M) genotypes; SEQ ID NO.11 and SEQ ID NO.12 aiming at IVS2-654C->T(654M) and 654M/654M genotypes; and SEQ ID NO.13 and SEQ ID NO.14 aiming at constant spring (CS), Quong Sze (QS) and Westmead (WS) genotypes. The kit has the advantages of good detection specificity and high detection sensitivity.